We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Wasting cash—the decline of the British biotech sector.
- Authors
Smith, Graham; Akram, Muhammad Safwan; Redpath, Keith; Bains, William
- Abstract
The article assesses the decline of the biotechnology industry in Great Britain. The authors assert that this decline can be attributed to a combination of severe undercapitalization of British companies, overgenerous remuneration to board members and absence of share- or performance-related reward for top executives. Compared to its American counterpart, the British biotechnology industry has no world-class companies in the mold of Amgen, Genentech or Genzyme. British companies also failed to invest their limited resources in product development and innovative therapeutics.
- Subjects
UNITED Kingdom; BIOTECHNOLOGY industries; CORPORATE finance; CORPORATE directors' salaries; LABOR incentives; RESOURCE allocation
- Publication
Nature Biotechnology, 2009, Vol 27, Issue 6, p531
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0609-531